Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress.
Blood 2011, 117 (3), 857-61
Antibody-dependent natural killer cell-mediated cytotoxicity engendered by a kinase-inactive human HER2 adenovirus-based vaccination mediates resistance to breast tumors.
Cancer Res 2010, 70 (19), 7431-41
Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign.
Cancer Res 2010, 70 (11), 4335-45
Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death.
Blood 2009, 113 (15), 3542-5
Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity.
Cancer Res 2006, 66 (12), 6387-94
DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth.
Proc Natl Acad Sci U S A 2006, 103 (24), 9208-13
Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines.
Int J Cancer 2004, 108 (1), 71-7
Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma.
Cancer Res 1993, 53 (23), 5610-2
Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defense strategy.
Nature 1986, 319, 675-678
Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts.
Eur J Immunol 1977, 7 (9), 655-63
"Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell.
Eur J Immunol 1975, 5 (2), 117-21